HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer.
Rasiah KK, Gardiner-Garden M, Padilla EJ, Möller G, Kench JG, Alles MC, Eggleton SA, Stricker PD, Adamski J, Sutherland RL, Henshall SM, Hayes VM.
Rasiah KK, et al. Among authors: padilla ej.
Mol Cell Endocrinol. 2009 Mar 25;301(1-2):89-96. doi: 10.1016/j.mce.2008.11.021. Epub 2008 Nov 28.
Mol Cell Endocrinol. 2009.
PMID: 19100308